Basic Information
Basic information for UCA1-216-15aa
Peptide Name UCA1-216-15aa
Genome Position chr19:15834836-15834880[+]
Species Human
Peptide Sequence MLPSRLHPFLWTLIS
Peptide Length 15
Unique No (UCA1-201-15aa,UCA1-202-15aa-2,UCA1-203-15aa,UCA1-204-15aa,UCA1-205-15aa-2,UCA1-207-15aa,UCA1-208-15aa,UCA1-210-15aa,UCA1-211-15aa,UCA1-212-15aa,UCA1-213-15aa,UCA1-214-15aa,UCA1-215-15aa,UCA1-218-15aa,UCA1-220-15aa,UCA1-221-15aa,UCA1-222-15aa,UCA1-223-15aa,UCA1-224-15aa,UCA1-225-15aa,UCA1-226-15aa,UCA1-227-15aa,UCA1-229-15aa,UCA1-232-15aa,UCA1-233-15aa,UCA1-234-15aa,UCA1-235-15aa,UCA1-237-15aa,UCA1-238-15aa,UCA1-240-15aa,UCA1-243-15aa,UCA1-244-15aa)
Grand Average of Hydropathicity 0.6867
Relative Molecular Mass 2063.43
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000214049;UCA1
Transcript ID/Name ENST00000644567;UCA1-216
Transcript Length 2627
Coding Ability 0.3955
DNA Sequence Corresponding to Peptide ATGCTTCCAAGCAGGCTTCATCCGTTCCTCTGGACCCTCATCTCT
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :